KMTS vs TSLA · rev $95.1M vs P/E 179, rev $28.24B
Kestra Medical Technologies, Ltd. Common Stock (KMTS) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
Latest reported TSLA revenue for 2026-06-30 was $28.24B. Net income was $1.11B. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
KMTS currently screens at market cap $1.24B. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the KMTS and TSLA stock pages for the full models.
Not investment advice.